As of 2025-07-06, the Fair Value of Intra-Cellular Therapies Inc (ITCI) is -3.51 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 131.87 USD, the upside of Intra-Cellular Therapies Inc is -102.66%.
With the market price of 131.87 USD and our fair value calculation, Intra-Cellular Therapies Inc (ITCI) is not a good investment. Investing in ITCI stocks now will result in a potential loss of 102.66%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -227.00 | -284.10 | -256.30 | -139.67 | -74.68 | -196.35 |
| YoY growth | -53.69% | -25.15% | 9.79% | 45.50% | 46.54% | 4.60% |
| Market Cap (mil) | 14,046.79 |
| P/E | |
| Forward P/E |
| EPS | -0.70 |
| Avg earnings growth rate | 4.60% |
| TTM earnings | -74.68 |